NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Structured Abstract
Objectives:
Cataract and glaucoma are ocular diseases that often coexist, with prevalences over age 40 of 20 percent and two percent, respectively. There is no agreement concerning their optimal management when coexistent. We prepared this evidence report to: identify the important questions pertinent to surgical treatment of coexisting cataract and glaucoma; assess the quality and content of evidence on surgical treatment of coexisting cataract and glaucoma; and inform clinical practitioners and identify areas for future research.
Search Strategy:
The searches were conducted on publications from 1980 to April 2000 using two electronic databases, PubMed and CENTRAL. Text words and Medical Subject Heading (MeSH) search terms used included (“cataract” and “glaucoma”) and (“surgery” or “filtering surgery” or “cataract extraction” or “sclerostomy” or “trabeculectomy” or “phacoemulsification”). We included variants of “randomized controlled trials” in the search as well as “case report” and “case series”. The electronic searches were augmented by a hand search of primary journals.
Selection Criteria:
Two individuals independently reviewed each abstract. The exclusion criteria were: no human data, lack of adults, lack of original data, failure to address open-angle or primary angle- closure glaucoma, not a controlled trial nor a case series greater than or equal to 100 eyes, only addressing intracapsular surgery, only addressing full-thickness procedures, was a meeting abstract, and not in English.
Data Collection and Analysis:
Two data abstraction forms were developed. The 25 question quality assessment form was divided into the following categories: representativeness, bias and confounding, description of therapy, outcomes and followup, and statistical quality and interpretation. A content assessment form was developed through an iterative process.
Each article was reviewed by two reviewers, at least one trained in research methodology and at least one trained in ophthalmology. Quality scores for each controlled trial and cohort study were tabulated.
For each study question one member of the analysis team summarized the extracted data and formulated a conclusion about the answer to each question. For each conclusion, the entire study team assigned an evidence grade of A (strong), B (intermediate), C (weak), or I (insufficient).
Main Results:
There was strong evidence that glaucoma surgery is associated with an increased risk of postoperative cataract; moderately strong evidence that mitomycin-C, but not 5-fluorouracil is beneficial in combined procedures, limbus- and fornix-based conjunctival incisions are equally effective for lowering IOP, and the size of the phacoemulsification incision is not important; and weak evidence that combined procedures using phacoemulsification rather than nuclear expression result in lower long-term IOP, as do two-site compared to one-site combined procedures.
Limitations of the literature included lack of optic nerve and visual field data, lack of objective description of the ocular lens, inconclusive information on complications, lack of patient preference and quality of life data, and limited followup in many studies.
Conclusions:
The literature does not point to one optimal strategy for controlling IOP in patients with coexisting cataract and glaucoma needing surgery. Therefore, there is a continued need for high quality studies with greater duration and more information on optic nerve and visual field findings.
Contents
- Preface
- Summary
- 1. Introduction
- 2. Methodology
- 3. Results
- 4. Conclusions
- 5. Future Research
- Evidence Tables
- Acronyms and Abbreviations Used in the Evidence Tables
- Appendixes
- Appendix A - Peer Review Representatives of Stakeholder Organizations
- Appendix B - Question Refinement Mailing
- Appendix C - PubMed Core Strategy
- Appendix D - Priority Journals
- Appendix E - Abstract Review Form
- Appendix F - Article Quality Assessment Form
- Appendix G - Article Content Abstraction Form
- Appendix H - List of Questions Addressed by Literature Review and Associated Evidence Tables
- Appendix I - Initial Evidence Grade Assignments
- Appendix J - Searching Summary
- APPENDIX K - Reasons for exclusion during abstract review process
- Appendix L - Study topics assigned during abstract review
- APPENDIX M - Articles excluded during quality assessment
- Appendix N - Reasons for exclusion during quality assessment
- Appendix O - Study Topics Assigned During Quality Assessment
- Appendix P - Article Summary Information for Study Topics
- Appendix Q - Quality assessment category scores a
- References
- Bibliography
Investigators: Karen A Robinson, MSc, Nathan Congdon, MD, MPH, Harry A Quigley, MD, Hanna Levkovitch-Verbin, MD, John Kempen, MD, MPH, and Eric B Bass, MD, MPH.
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.1 Contract No. 290-97-0006. Prepared by: Johns Hopkins University Evidence-based Practice Center, Baltimore, MD.
Suggested citation:
Jampel H, Lubomski L, Friedman D. Treatment of Coexisting Cataract and Glaucoma. Evidence Report/Technology Assessment Number 38. (Prepared by Johns Hopkins University Evidence-based Practice Center under Contract No. 290-97-0006.) AHRQ Publication No. 03-E041. Rockville, MD: Agency for Healthcare Research and Quality. June 2003.
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakers—patients and clinicians, health system leaders, and policymakers—make more informed decisions and improve the quality of health care services.
The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical service.
- Review Combined cataract and glaucoma surgeries: traditional and new combinations.[Int Ophthalmol Clin. 2010]Review Combined cataract and glaucoma surgeries: traditional and new combinations.Rosdahl JA, Chen TC. Int Ophthalmol Clin. 2010 Winter; 50(1):95-106.
- Review Combined procedures in glaucoma surgery.[Semin Ophthalmol. 2001]Review Combined procedures in glaucoma surgery.Mizoguchi T, Kuroda S, Terauchi H, Nagata M. Semin Ophthalmol. 2001 Sep; 16(3):139-43.
- Review Surgical management of coincident cataract and glaucoma.[Curr Opin Ophthalmol. 1997]Review Surgical management of coincident cataract and glaucoma.Samuelson TW. Curr Opin Ophthalmol. 1997 Feb; 8(1):39-45.
- Review Role of Cataract Surgery in the Management of Glaucoma.[Int Ophthalmol Clin. 2018]Review Role of Cataract Surgery in the Management of Glaucoma.Ling JD, Bell NP. Int Ophthalmol Clin. 2018 Summer; 58(3):87-100.
- Review Management of Concomitant Cataract and Glaucoma.[Dev Ophthalmol. 2017]Review Management of Concomitant Cataract and Glaucoma.Marchini G, Ceruti P, Vizzari G, Berzaghi D, Zampieri A. Dev Ophthalmol. 2017; 59:155-164. Epub 2017 Apr 25.
- Treatment of Coexisting Cataract and GlaucomaTreatment of Coexisting Cataract and Glaucoma
Your browsing activity is empty.
Activity recording is turned off.
See more...